History
|
30 years ago a group of Russian scientists, doctors, engineers and physicians from Special Construction
Bureau “RITM” commenced development work on the concept of SCENAR or Self-Controlled-Energo-Neuro-Adaptive
Regulator invented by A. Karasev and A. Revenko. Their goal was to develop a method of treatment that was
energy efficient, multi-applicable, portable and universal non-invasive regulator of body functions,
perhaps even suitable to accompany cosmonauts into space.
|
|
SCENAR technology as a therapy was born in 1978. The method of treatment was invented by A. Revenko.
The SCENAR device is capable of recognizing, preventing many health problems and restoring health.Russians
pioneers were the first to successfully achieve repeatable therapeutic treatment using electrical signals
to stimulate the human Immune System in aim to stimulate the body to heal, using modulations of its own
endogenous energy.
|
|
In 1986, the first SCENAR device, having passed technical and clinical trials, was permitted
by USSR Medical Council for application in the clinic-policlinic institutions and at homes.
|
|
The SCENAR (Biofeedback-controlled electro-stimulator) is regulated by the United States Food and Drug
Administration, under 21 CFR 882.5050. Generic Name: device, Biofeedback, Product Code HCC, Class II exempt
from 510 (K) pre-market notification according to FDA Notice FR21ja98-84 as a battery-powered, professional
use device for relaxation training and muscle re-education.
|
|
"SCENAR" is a trademark (according to class - therapeutic device and apparatus, electro-stimulators),
registered in the state list of trademarks in USSR from 23 October 1989 by RITM.
|
|
Further research has been conducted at laboratories in the cities of Taganrog, Ekaterinburg and Chelyabinsk.
In the last 12 years, more than 20 modifications have been developed ranging from the simplest hand-held
devices to the most complex computer applications. SCENAR has brought to its creators the highest state awards.
|
|
SCENAR become available to the broad medical community after the Soviet Union collapse and since then
the device has been gaining vast popularity and application among medical and health care practitioner throughout
the world including UK, United States, Canada, Europe, and Australia.
|
|
In 2006 RITM has successfully certified its products and activities under the International Quality
Standards ISO 9001 and ISO 13485. RITM SCENAR devices also comply with the European Directive 93/42/EEC
for Manufacturing Medical Devices (CE Mark), obtained in 2006.
|
|
The innovations in device development and treatment methodology keep RITM far ahead of the competition
a true world leader in development of biological feedback electric impulse therapy devices.
|
|
The latest generation of SCENAR devices was patented by RITM with joint authorship: Y.Gorfinkel, J. Grinberg,
M. Zenkin, A. Murancev, A. Nadtochii, A. Revenko, M. Unakafov, S. Uvarov.
|
Treatment methodologies are developed by: A.Revenko, A.Karasev, A.Nechishkin and Y.Gorfinkel.
The authors of the latest treatment methodologies are: A.Revenko, T.Tarakanova, B.Kolijskii, G.Subbotina,
J.Grinberg and M.Unakafov.
|
|
|